Mettler-Toledo International Inc. (MTD) 10-Year Financial Performance & Capital Metrics

MTD • • Industrial / General

HealthcareDiagnostics & ResearchLife Sciences Instrumentation & ToolsLaboratory Equipment & Consumables

AboutMettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.Show more

Revenue $3.87B +2.2%
EBITDA $1.25B +4.1%
Net Income $863M +9.4%
EPS (Diluted) 40.67 +13.3%
Gross Margin 58.17% +1.6%
EBITDA Margin 32.29% +1.9%
Operating Margin 29.11% +2.1%
Net Margin 22.29% +7.1%
ROE -
ROIC 43.11% +7.4%
Debt/Equity -
Interest Coverage 15.10 +8.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 889.3%
✓Strong Piotroski F-Score: 7/9
✓FCF machine: 22.3% free cash flow margin
✓Share count reduced 3.0% through buybacks
✓Healthy 5Y average net margin of 21.1%
✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.53%

5Y5.18%

3Y1.37%

TTM4.77%

Profit (Net Income) CAGR

10Y9.82%

5Y9%

3Y3.93%

TTM5.04%

EPS CAGR

10Y13.52%

5Y12.6%

3Y7.45%

TTM8.28%

ROCE

10Y Avg42.06%

5Y Avg47.53%

3Y Avg50.22%

Latest53.08%

Peer Comparison

Laboratory Equipment & Consumables

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
QGENQiagen N.V.	9.77B	47.44	124.84	0.66%	19.58%	11.11%	5.18%	0.40
RVTYRevvity, Inc.	12.64B	111.52	46.27	0.16%	8.47%	3.23%	4.28%	0.43
DHRDanaher Corporation	168.08B	237.95	44.98	-0.06%	14.43%	6.86%	3.15%	0.35
TMOThermo Fisher Scientific Inc.	233.63B	621.83	37.62	0.05%	15.02%	12.84%	3.11%	0.66
WATWaters Corporation	23.41B	393.20	36.71	0.07%	20.89%	27.84%	2.65%	0.93
MTDMettler-Toledo International Inc.	30.35B	1485.56	36.53	2.22%	21.2%		2.85%
AAgilent Technologies, Inc.	41.37B	145.92	31.93	6.73%	18.75%	19.33%	2.78%	0.50
TWSTTwist Bioscience Corporation	2.45B	40.03	-30.79	20.32%	-23.51%	-17.81%		0.16

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.4B	2.51B	2.73B	2.94B	3.01B	3.09B	3.72B	3.92B	3.79B	3.87B
Revenue Growth %	-0.04%	0.05%	0.09%	0.08%	0.02%	0.03%	0.21%	0.05%	-0.03%	0.02%
Cost of Goods Sold+	1.06B	1.12B	1.19B	1.3B	1.32B	1.34B	1.61B	1.68B	1.62B	1.62B
COGS % of Revenue	0.44%	0.44%	0.44%	0.44%	0.44%	0.43%	0.43%	0.43%	0.43%	0.42%
Gross Profit+	1.33B	1.39B	1.53B	1.64B	1.69B	1.74B	2.11B	2.24B	2.17B	2.25B
Gross Margin %	0.56%	0.56%	0.56%	0.56%	0.56%	0.57%	0.57%	0.57%	0.57%	0.58%
Gross Profit Growth %	0%	0.04%	0.1%	0.07%	0.03%	0.03%	0.21%	0.06%	-0.03%	0.04%
Operating Expenses+	819.89M	852.59M	923.17M	953.87M	963.13M	960.32M	1.11B	1.12B	1.09B	1.13B
OpEx % of Revenue	0.34%	0.34%	0.34%	0.32%	0.32%	0.31%	0.3%	0.28%	0.29%	0.29%
Selling, General & Admin	700.81M	732.62M	787.46M	812.8M	819.18M	820.22M	943.98M	938.46M	904.11M	936.3M
SG&A % of Revenue	0.29%	0.29%	0.29%	0.28%	0.27%	0.27%	0.25%	0.24%	0.24%	0.24%
Research & Development	119.08M	119.97M	129.26M	141.07M	143.95M	140.1M	169.77M	177.12M	185.28M	189.36M
R&D % of Revenue	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	513.68M	540.19M	609.91M	682.98M	728.39M	784.04M	994.74M	1.13B	1.08B	1.13B
Operating Margin %	0.21%	0.22%	0.22%	0.23%	0.24%	0.25%	0.27%	0.29%	0.29%	0.29%
Operating Income Growth %	0.08%	0.05%	0.13%	0.12%	0.07%	0.08%	0.27%	0.13%	-0.04%	0.04%
EBITDA+	577.72M	608.98M	686.04M	767.67M	817.07M	882.75M	1.1B	1.24B	1.2B	1.25B
EBITDA Margin %	0.24%	0.24%	0.25%	0.26%	0.27%	0.29%	0.3%	0.32%	0.32%	0.32%
EBITDA Growth %	0.07%	0.05%	0.13%	0.12%	0.06%	0.08%	0.25%	0.12%	-0.03%	0.04%
D&A (Non-Cash Add-back)	64.04M	68.8M	76.13M	84.69M	88.68M	98.71M	108.06M	113.02M	121.16M	123.22M
EBIT	493.64M	531.18M	608.69M	685.83M	723.3M	787.25M	991.83M	1.13B	1.06B	1.1B
Net Interest Income+	-27.45M	-28.03M	-32.78M	-34.51M	-37.41M	-38.62M	-43.24M	-55.39M	-77.37M	-74.63M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	27.45M	28.03M	32.78M	34.51M	37.41M	38.62M	43.24M	55.39M	77.37M	74.63M
Other Income/Expense	-50.26M	-36M	-35.69M	-31.12M	-46.99M	-35.3M	-45.38M	-55.63M	-105.95M	-89.83M
Pretax Income+	463.42M	504.19M	574.22M	651.86M	681.39M	748.74M	949.36M	1.07B	973.73M	1.04B
Pretax Margin %	0.19%	0.2%	0.21%	0.22%	0.23%	0.24%	0.26%	0.27%	0.26%	0.27%
Income Tax+	110.6M	119.82M	198.25M	139.25M	120.28M	146M	180.38M	198.09M	184.95M	174.08M
Effective Tax Rate %	0.76%	0.76%	0.65%	0.79%	0.82%	0.81%	0.81%	0.81%	0.81%	0.83%
Net Income+	352.82M	384.37M	375.97M	512.61M	561.11M	602.74M	768.99M	872.5M	788.78M	863.14M
Net Margin %	0.15%	0.15%	0.14%	0.17%	0.19%	0.2%	0.21%	0.22%	0.21%	0.22%
Net Income Growth %	0.04%	0.09%	-0.02%	0.36%	0.09%	0.07%	0.28%	0.13%	-0.1%	0.09%
Net Income (Continuing)	352.82M	384.37M	375.97M	512.61M	561.11M	602.74M	768.99M	872.5M	788.78M	863.14M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	12.48	14.22	14.24	19.88	22.47	24.91	32.78	38.41	35.90	40.67
EPS Growth %	0.09%	0.14%	0%	0.4%	0.13%	0.11%	0.32%	0.17%	-0.07%	0.13%
EPS (Basic)	12.75	14.49	14.62	20.33	22.84	25.24	33.25	38.79	36.10	40.67
Diluted Shares Outstanding	28.27M	27.02M	26.39M	25.78M	24.97M	24.2M	23.46M	22.72M	21.97M	21.32M
Basic Shares Outstanding	27.68M	26.52M	25.71M	25.22M	24.57M	23.88M	23.13M	22.49M	21.85M	21.22M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	795.33M	896.78M	1.01B	1.05B	1.11B	1.06B	1.27B	1.38B	1.23B	1.19B
Cash & Short-Term Investments	98.89M	158.67M	148.69M	178.11M	207.78M	94.25M	98.56M	95.97M	69.81M	59.36M
Cash Only	98.89M	158.67M	148.69M	178.11M	207.78M	94.25M	98.56M	95.97M	69.81M	59.36M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	411.42M	454.99M	528.62M	535.53M	566.26M	593.81M	647.34M	709.32M	663.89M	687.11M
Days Sales Outstanding	62.69	66.21	70.8	66.59	68.7	70.25	63.55	66.05	63.97	64.77
Inventory	214.38M	222.05M	255.39M	268.82M	274.29M	297.61M	414.54M	441.69M	385.87M	342.27M
Days Inventory Outstanding	73.69	72.66	78.2	75.55	76.01	81.02	94.01	96.08	86.98	77.13
Other Current Assets	70.64M	61.08M	74.03M	63.4M	61.32M	71.23M	108.92M	128.11M	110.64M	105.16M
Total Non-Current Assets+	1.16B	1.27B	1.54B	1.57B	1.68B	1.76B	2.06B	2.12B	2.13B	2.05B
Property, Plant & Equipment	517.23M	563.71M	668.27M	717.53M	748.66M	798.87M	799.37M	778.6M	803.37M	770.28M
Fixed Asset Turnover	4.63x	4.45x	4.08x	4.09x	4.02x	3.86x	4.65x	5.03x	4.72x	5.03x
Goodwill	446.28M	476.38M	539.84M	534.78M	535.98M	550.27M	648.62M	660.17M	670.11M	668.91M
Intangible Assets	115.25M	167.06M	226.72M	217.31M	206.24M	196.78M	307.45M	306.05M	285.43M	257.14M
Long-Term Investments	0	0	0	0	0	0	2.12M	6.89M	0	398K
Other Non-Current Assets	52.19M	28.9M	66.83M	68.31M	151.82M	169.89M	260.39M	338.51M	335.24M	314.77M
Total Assets+	1.96B	2.17B	2.55B	2.62B	2.79B	2.81B	3.33B	3.49B	3.36B	3.24B
Asset Turnover	1.22x	1.16x	1.07x	1.12x	1.08x	1.10x	1.12x	1.12x	1.13x	1.20x
Asset Growth %	-0.02%	0.11%	0.18%	0.03%	0.07%	0.01%	0.18%	0.05%	-0.04%	-0.03%
Total Current Liabilities+	558.21M	587.51M	689.67M	734.43M	754.51M	840.33M	1.15B	1.15B	1.18B	1.17B
Accounts Payable	142.07M	146.59M	167.63M	196.64M	185.59M	175.8M	272.91M	252.54M	210.41M	215.84M
Days Payables Outstanding	48.84	47.97	51.33	55.26	51.43	47.86	61.89	54.94	47.43	48.64
Short-Term Debt	14.49M	18.97M	19.68M	49.67M	55.87M	50.32M	131.77M	135.32M	220.74M	212.44M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	136.41M	140.46M	170.16M	152.52M	155.4M	179.25M	172.62M	170.75M	160.31M	152.45M
Current Ratio	1.42x	1.53x	1.46x	1.42x	1.47x	1.26x	1.11x	1.20x	1.04x	1.02x
Quick Ratio	1.04x	1.15x	1.09x	1.06x	1.11x	0.90x	0.75x	0.81x	0.71x	0.73x
Cash Conversion Cycle	87.54	90.9	97.68	86.87	93.27	103.41	95.67	107.2	103.52	93.26
Total Non-Current Liabilities+	820.67M	1.14B	1.31B	1.29B	1.61B	1.69B	2.01B	2.32B	2.32B	2.2B
Long-Term Debt	575.14M	875.06M	960.17M	985.02M	1.24B	1.28B	1.58B	1.91B	1.89B	1.83B
Capital Lease Obligations	0	0	0	0	0	0	88.32M	86.89M	86.93M	87.37M
Deferred Tax Liabilities	50.98M	64.31M	51.23M	48.82M	45.27M	34.45M	62.23M	111.36M	108.68M	103.95M
Other Non-Current Liabilities	194.55M	204.96M	301.45M	260.51M	333.41M	372.93M	277.49M	213.14M	240.18M	176.11M
Total Liabilities	1.38B	1.73B	2B	2.03B	2.37B	2.53B	3.16B	3.47B	3.51B	3.37B
Total Debt+	589.63M	894.03M	979.85M	1.03B	1.29B	1.33B	1.8B	2.13B	2.2B	2.13B
Net Debt	490.74M	735.36M	831.16M	856.58M	1.08B	1.24B	1.7B	2.03B	2.13B	2.07B
Debt / Equity	1.02x	2.06x	1.79x	1.75x	3.07x	4.72x	10.51x	85.94x	-	-
Debt / EBITDA	1.02x	1.47x	1.43x	1.35x	1.58x	1.51x	1.63x	1.72x	1.83x	1.70x
Net Debt / EBITDA	0.85x	1.21x	1.21x	1.12x	1.33x	1.40x	1.54x	1.64x	1.77x	1.66x
Interest Coverage	18.71x	19.27x	18.60x	19.79x	19.47x	20.30x	23.00x	20.33x	13.96x	15.10x
Total Equity+	580.46M	434.94M	547.28M	590.06M	420.78M	282.68M	171.42M	24.79M	-149.94M	-126.89M
Equity Growth %	-0.19%	-0.25%	0.26%	0.08%	-0.29%	-0.33%	-0.39%	-0.86%	-7.05%	0.15%
Book Value per Share	20.53	16.09	20.74	22.89	16.85	11.68	7.31	1.09	-6.82	-5.95
Total Shareholders' Equity	580.46M	434.94M	547.28M	590.06M	420.78M	282.68M	171.42M	24.79M	-149.94M	-126.89M
Common Stock	448K	448K	448K	448K	448K	448K	448K	448K	448K	448K
Retained Earnings	2.69B	3.07B	3.43B	3.94B	4.5B	5.1B	5.86B	6.73B	7.51B	8.37B
Treasury Stock	-2.54B	-3.01B	-3.37B	-3.81B	-4.54B	-5.28B	-6.26B	-7.33B	-8.21B	-9.05B
Accumulated OCI	-266.65M	-355M	-265.41M	-302.41M	-323.67M	-334.93M	-255.22M	-227.23M	-319.81M	-345.86M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	426.87M	443.08M	516.33M	565M	603.45M	724.7M	908.83M	859.07M	965.87M	968.35M
Operating CF Margin %	0.18%	0.18%	0.19%	0.19%	0.2%	0.23%	0.24%	0.22%	0.25%	0.25%
Operating CF Growth %	0.02%	0.04%	0.17%	0.09%	0.07%	0.2%	0.25%	-0.05%	0.12%	0%
Net Income	352.82M	384.37M	375.97M	512.61M	561.11M	602.74M	768.99M	872.5M	788.78M	863.14M
Depreciation & Amortization	64.04M	68.8M	76.13M	84.69M	88.68M	98.71M	108.06M	113.02M	121.16M	123.22M
Stock-Based Compensation	14.22M	15.31M	16.58M	17.58M	18.29M	18.69M	19.59M	19.66M	17.93M	19.98M
Deferred Taxes	7.26M	1.88M	69.24M	5.9M	-4.63M	-12.78M	563K	26.52M	-13.37M	-28.2M
Other Non-Cash Items	-12.77M	-9.31M	-3.15M	-21.23M	133K	-2.4M	7.23M	0	0	0
Working Capital Changes	1.3M	-17.96M	-18.44M	-34.54M	-60.13M	19.75M	4.39M	-172.64M	51.38M	-9.8M
Change in Receivables	1.63M	-52.15M	-38.98M	-19.54M	-31.41M	-4.5M	-66.47M	-83.42M	50.3M	-53M
Change in Inventory	-18.79M	-12.43M	-13.68M	-21.2M	-4.6M	-3.84M	-118.72M	-43.39M	71.02M	24.13M
Change in Payables	1.7M	9.63M	11.88M	33.67M	-12.22M	-17.8M	93.97M	-13.83M	-40.55M	12.08M
Cash from Investing+	-100.75M	-231.46M	-217.34M	-138.94M	-99.08M	-100.36M	-314.11M	-139.4M	-131.69M	-119.46M
Capital Expenditures	-82.51M	-123.96M	-127.43M	-142.73M	-97.34M	-92.49M	-107.58M	-121.24M	-105.32M	-103.9M
CapEx % of Revenue	0.03%	0.05%	0.05%	0.05%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-4.47M	3.88M	18.53M	9.31M	262K	-1.62M	14.33M	19.8M	-20.56M	-15.56M
Cash from Financing+	-307.03M	-145.93M	-319.53M	-388.02M	-477.37M	-743.91M	-590.55M	-716.04M	-859.59M	-855.98M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	40.55M	42.47M	21.44M	22.69M	39.33M	25.92M	17.48M	24.1M	10.64M	12.75M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	344.36M	319.12M	388.9M	422.28M	506.11M	632.21M	801.25M	737.83M	860.55M	864.45M
FCF Margin %	0.14%	0.13%	0.14%	0.14%	0.17%	0.2%	0.22%	0.19%	0.23%	0.22%
FCF Growth %	0.05%	-0.07%	0.22%	0.09%	0.2%	0.25%	0.27%	-0.08%	0.17%	0%
FCF per Share	12.18	11.81	14.73	16.38	20.27	26.13	34.16	32.48	39.17	40.54
FCF Conversion (FCF/Net Income)	1.21x	1.15x	1.37x	1.10x	1.08x	1.20x	1.18x	0.98x	1.22x	1.12x
Interest Paid	27.3M	28.02M	33.33M	34.45M	37.5M	37.77M	41.34M	52.31M	75.62M	75.94M
Taxes Paid	85.46M	92.59M	109.73M	132.41M	129.35M	134.67M	152.66M	114.04M	178.25M	209.37M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	54.28%	75.71%	76.56%	90.14%	111.02%	171.37%	338.69%	889.34%	-	-
Return on Invested Capital (ROIC)	35.71%	36.15%	35.89%	36.26%	37.03%	38.85%	43.93%	42.95%	40.13%	43.11%
Gross Margin	55.67%	55.53%	56.26%	55.76%	56.22%	56.54%	56.71%	57.19%	57.26%	58.17%
Net Margin	14.73%	15.32%	13.8%	17.46%	18.65%	19.54%	20.68%	22.26%	20.82%	22.29%
Debt / Equity	1.02x	2.06x	1.79x	1.75x	3.07x	4.72x	10.51x	85.94x	-	-
Interest Coverage	18.71x	19.27x	18.60x	19.79x	19.47x	20.30x	23.00x	20.33x	13.96x	15.10x
FCF Conversion	1.21x	1.15x	1.37x	1.10x	1.08x	1.20x	1.18x	0.98x	1.22x	1.12x
Revenue Growth	-3.64%	4.71%	8.64%	7.73%	2.49%	2.54%	20.51%	5.43%	-3.35%	2.22%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Laboratory products and services	1.15B	1.23B	1.36B	1.5B	1.58B	1.67B	2.08B	2.23B	2.07B	2.19B
Laboratory products and services Growth	-	6.07%	10.90%	10.76%	4.92%	5.78%	24.75%	7.07%	-7.24%	5.66%
Industrial products and services	1.03B	1.07B	1.16B	1.21B	1.23B	1.22B	1.45B	1.51B	1.49B	1.49B
Industrial products and services Growth	-	3.24%	8.47%	4.58%	1.87%	-0.77%	18.13%	4.43%	-1.33%	-0.03%
Retail products and services	206.23M	215.4M	208.22M	219.62M	196.06M	190.89M	188.36M	178.77M	229.06M	196.36M
Retail products and services Growth	-	4.44%	-3.33%	5.47%	-10.73%	-2.64%	-1.32%	-5.09%	28.13%	-14.28%

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Americas	157.96M	153.61M	162.67M	172.54M	1.35B	1.18B	1.42B	1.58B	1.57B	1.61B
Americas Growth	-	-2.76%	5.90%	6.06%	680.80%	-12.36%	20.26%	11.46%	-0.90%	2.43%
Asia	696.22M	740.54M	824.21M	-	950.71M	983.28M	1.24B	1.32B	1.2B	1.17B
Asia Growth	-	6.36%	11.30%	-	-	3.43%	25.61%	7.10%	-8.94%	-3.23%
Europe	349.18M	374.01M	399.92M	426.21M	1.33B	921.27M	1.06B	1.01B	1.02B	1.1B
Europe Growth	-	7.11%	6.93%	6.57%	211.10%	-30.52%	15.38%	-4.57%	0.11%	8.36%

Frequently Asked Questions

Valuation & Price

Mettler-Toledo International Inc. (MTD) has a price-to-earnings (P/E) ratio of 36.5x. This suggests investors expect higher future growth.

Growth & Financials

Mettler-Toledo International Inc. (MTD) reported $3.94B in revenue for fiscal year 2024. This represents a 71% increase from $2.31B in 2011.

Mettler-Toledo International Inc. (MTD) grew revenue by 2.2% over the past year. Growth has been modest.

Yes, Mettler-Toledo International Inc. (MTD) is profitable, generating $835.7M in net income for fiscal year 2024 (22.3% net margin).

Dividend & Returns

Mettler-Toledo International Inc. (MTD) generated $889.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...